Corbus Pharmaceuticals, Inc.
🏢 View company profile →6Patents
6Active
6Granted
42Portfolio score
Filing activity: Jul 26, 2016 → May 29, 2019
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9820964B2 | Ultrapure tetrahydrocannabinol-11-oic acids | Human Necessities | 4 | Active |
| US10154986B2 | Ultrapure tetrahydrocannabinol-11-oic acids | Human Necessities | 2 | Active |
| US10369131B2 | Ultrapure tetrahydrocannabinol-11-oic acids | Human Necessities | 1 | Active |
| US10085964B2 | Ultrapure tetrahydrocannabinol-11-oic acids | Human Necessities | 1 | Active |
| US9801849B2 | Ultrapure tetrahydrocannabinol-11-oic acids | Human Necessities | 1 | Active |
| US11052066B2 | Ultrapure tetrahydrocannabinol-11-oic acids | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.